Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
4
50%
Ph phase_2
1
13%
Ph phase_4
2
25%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 42 (28.6%)
N/A4 (57.1%)

Trials by Status

withdrawn113%
completed675%
unknown113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8